The iShares US Pharmaceuticals ETF is up ~3.1% on Tuesday, outperforming other ETFs. Within the fund, Crinetics Pharmaceuticals surged ~98.8% and Trevi Therapeutics rose ~10.6%, indicating strong relative momentum in select biotech names.
The iShares US Pharmaceuticals ETF is up ~3.1% on Tuesday, outperforming other ETFs. Within the fund, Crinetics Pharmaceuticals surged ~98.8% and Trevi Therapeutics rose ~10.6%, indicating strong relative momentum in select biotech names.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately positive
Sentiment Score
0.35
Ticker Sentiment
